Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMJUVE6)

Drug Name

Bulevirtide Drug Info

Synonyms

Lipopeptide

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis D virus infection	1E51.2	Approved	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Sodium/bile acid cotransporter (SLC10A1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Lum001	DMQZXDW	Primary biliary cholangitis	DB96.1	Phase 2	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Sodium/bile acid cotransporter (SLC10A1)	TTWZRY5	NTCP_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03852719) Phase 3 Study of Bulevirtide in Patients With CHD. U.S. National Institutes of Health.
2	Bulevirtide: First Approval. Drugs. 2020 Oct;80(15):1601-1605.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)